Articles about Oxford

On Thursday night, the Pune Airport was prepared to airlift vials of coronavirus vaccine, the first such exercise in India's massive inoculation drive.

A dry run for vaccination, before the actual doses of the coronavirus vaccine are administered to people, will be held in all states and union territories today.

India recorded less than 300 deaths linked to coronavirus every day between last Thursday and today, the government said.

In a development that will soothe the coronavirus-battered nation, the Central Drugs Standard Control Organization (CDSCO) panel on Friday gave approval to the vaccine developed by the University of Oxford and British-pharma giant AstraZeneca.

After the meeting on Wednesday to judge the emergency use authorization applications of coronavirus vaccine developers remained without a conclusion, the subject expert committee (SEC) will meet again today.

The University of Oxford and pharmaceutical firm AstraZeneca became the first coronavirus vaccine developers to release their final-stage clinical trial data.

Pune-based Serum Institute of India (SII) has sought emergency use authorization from Drugs Controller General of India (DCGI) for the coronavirus vaccine, which is developed by the University of Oxford and the British-pharma giant AstraZeneca, multiple reports said.

The Serum Institute of India (SII) has said that it will seek Rs. 100 crore in damages from a COVID-19 vaccine trial participant for complaining about side-effects.

After announcing that their coronavirus vaccine candidate was nearly 70% effective, the University of Oxford and its partner, AstraZeneca, on Wednesday admitted to a manufacturing error, which has now sparked important questions about the results.

The CEO of the Serum Institute of India (SII), Adar Poonawalla, has said that the institute can roll out 100 million doses of the COVID-19 vaccine by January-February.

The coronavirus vaccine being developed by Oxford University and British pharma giant AstraZeneca is 70% effective, results from large-scale trials have shown, multiple reports said on Monday.

With heartening news of the coronavirus vaccine coming from different parts of the world, the Indian government is trying to understand which one would be the most feasible for the country.

Adar Poonawalla, the CEO of Serum Institute of India, said that the vaccine against coronavirus will be available in India by January 2021, two months from now, provided that the government gives approvals on time.

In a welcome piece of development, Serum Institute of India's CEO Adar Poonawalla said on Wednesday that the coronavirus vaccine, being developed by Oxford University, could be available for use in India by December 2020.

The COVID-19 vaccine being developed by Oxford University and AstraZeneca generates similar immune responses among younger and older adults, the pharmaceutical company has said.

A volunteer involved with the trial of coronavirus vaccine developed by AstraZeneca and Oxford University has died, Brazil's health authority Anvisa informed on Wednesday.

Last night, the US Senate Commerce Committee voted unanimously to issue subpoenas to the CEOs of Facebook, Google, and Twitter.

16 matches were held in the second round of the Carabao Cup.

Drugs Controller General of India (DCGI) Dr. VG Somani has permitted the Serum Institute of India (SII) to resume trial of the coronavirus vaccine candidate, being developed by the University of Oxford, revoking the last week's order that halted the process.

Last night, multiple reports suggested that ByteDance is likely to miss the September 20 deadline for finalizing the sale of TikTok's US assets.

A day after deciding to not halt the trial of the coronavirus vaccine, developed by the University of Oxford in collaboration with UK-pharma giant AstraZeneca, the Serum Institute of India (SII) on Thursday said it was also pausing the process.

Last night, TikTok was reported to be considering a way out of selling its US business to an American company.

Drug Controller General of India (DCGI) sent a notice to the Serum Institute of India (SII) asking why trials for the coronavirus vaccine candidate, developed by the University of Oxford, were not halted even when UK-based pharma giant AstraZeneca had stopped the process after a volunteer fell ill.

Last night, Samsung held the second part of Galaxy Unpacked event and gave an in-depth look at its latest foldable phone - the Z Fold2.

In the last few hours, renowned tech giants took major strides.

In a bid to exit the COVID-19 pandemic for good, Australia has secured access to a "promising vaccine."

India should have a vaccine to exit the COVID-19 pandemic by the end of this year.

In a major development, the Serum Institute of India has confirmed that the price of its foreign-licensed COVID-19 vaccines will be capped at $3 per dose in low-to-middle-income nations.

Serum Institute of India (SII) is set to source the COVID-19 vaccine developed by American biotech company Novavax.

A lot has happened over the weekend.

The Serum Institute of India (SII) has gotten the approval to conduct phase 2 and 3 human clinical trials of the COVID-19 vaccine candidate developed by Oxford University.

On January 30, television screens flashed reports of the first coronavirus patient in India - a student from Kerala who had returned from China's Wuhan.

At a time when the world is scrambling to develop a vaccine against coronavirus, a Union Minister launched a "papad" claiming it develops antibodies to fight the highly contagious disease.

Adar Poonawalla, the chief of Serum Institute of India (SII), is hoping that vaccine to fight coronavirus will be available in India by the first quarter of 2021.

A respite for the world battling the coronavirus pandemic, looks far-fetched, considering how easily the disease is spreading.

The COVID-19 vaccine developed by researchers at Oxford University in partnership with AstraZeneca generates an immune response against the infection in humans, The Telegraph reports.

With more than 5.3 lakh deaths and 1.14 crore infections, the COVID-19 pandemic continues to grow worse around the world.

COVID-19 has wreaked havoc around the world, leaving everyone desperate for a vaccine - a much-needed shot that prevents contraction or at least mitigates the severe impact of the novel coronavirus.

With a sporadic increase in the number of cases and deaths, COVID-19 is growing beyond control in India.

The outbreak of COVID-19, which has claimed over 2.5 lakh lives and put a third of the world's population under lockdown, has wrecked economies completely.